[The management for macular edema].
Yamamoto
Teiko
T
D000305:Adrenal Cortex Hormones / Q000494:pharmacology / Q000627:therapeutic use; D002199:Capillary Permeability; D016207:Cytokines / Q000502:physiology; D019299:Decompression, Surgical / Q000379:methods; D015195:Drug Design; D006801:Humans; D008269:Macular Edema / Q000209:etiology / Q000628:therapy*; D013508:Ophthalmologic Surgical Procedures / Q000379:methods; D011453:Prostaglandins / Q000502:physiology; D012161:Retinal Artery; D012169:Retinal Vein; D012170:Retinal Vein Occlusion / Q000150:complications / Q000601:surgery; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D014222:Triamcinolone Acetonide / Q000494:pharmacology / Q000627:therapeutic use; D014821:Vitrectomy / Q000379:methods
D000305:Adrenal Cortex Hormones; D016207:Cytokines; D011453:Prostaglandins; D010959:Tissue Plasminogen Activator; D014222:Triamcinolone Acetonide